Over 100 Seniors Die After Receiving Flu Shot
In the first study 2,573 adults ages 65 and older received the Fluzone high-dose and 1,260 received regular Fluzone shots. Out of those a surprising number of seniors, 156 high-dose and 93 regular-dose recipients, had a severe adverse event (SAE) within 6 months post-vaccination.
In addition, 16 high-dose and 7 regular-dose recipients died between 29 and 180 days post-vaccination. But as the package insert received by unsuspecting patients puts it, “no deaths were reported within 28 days post-vaccination.”
In the second study 15,992 adults ages 65 and older received the Fluzone high-dose and 15,991 received the regular Fluzone. Results show that 1,323 high-dose and 1,442 regular Fluzone recipients had a SAE within 6 to 8 months post-vaccination (204 high-dose and 200 regular-dose experienced a SAE within 30 days). In addition, 83 high-dose and 84 regular-dose died within 6 to 8 months, and 6 high-dose recipients died within 30 days post-vaccination.
According to the Fluzone vaccine information sheet none of these deaths were linked to the vaccine. They state that “these data do not provide evidence for a causal relationship between deaths and vaccination with Fluzone High-Dose.”
So a pharmaceutical funded study finds no “causal relationship” between deaths and vaccinations? Color me surprised. Here is the consent form you must sign if you get a flu shot from Rite Aid.
“I have read, or have had read to me the Vaccination Information Sheet (VIS) regarding the vaccine(s). I have had the opportunity to ask questions that were answered to my satisfaction and understand the benefits and risks of the vaccine(s). I consent to, or give consent for, the administration of the vaccine(s). I fully release and discharge Rite Aid Corporation, its affiliates, officers, directors, and employees from any liability for illness, injury, loss, or damage which may result there from,” states the Rite Aid consent form.
If these vaccines are so incredibly safe and routine, why on earth must we sign away liability?
A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly Adults
Other Outcome Measures:
Safety Overview After Injection With Either Fluzone High Dose or Fluzone Vaccine Through the End of Surveillance Period [ Time Frame: Day 0 up to Day 240 post-vaccination ] [ Designated as safety issue: No ]
All serious adverse events, including deaths and adverse events (AEs) of special interest (Guillain Barre Syndrome, Bell’s Palsy, encephalitis/myelitis, optic neuritis, Stevens Johnson Syndrome, and toxic epidermal necrolysis) were collected.
What is a Serious Adverse Event?
Report if you suspect that the death was an outcome of the adverse event, and include the date if known.
Report if suspected that the patient was at substantial risk of dying at the time of the adverse event, or use or continued use of the device or other medical product might have resulted in the death of the patient.
Hospitalization (initial or prolonged)
Report if admission to the hospital or prolongation of hospitalization was a result of the adverse event.
Emergency room visits that do not result in admission to the hospital should be evaluated for one of the other serious outcomes (e.g., life-threatening; required intervention to prevent permanent impairment or damage; other serious medically important event).
Disability or Permanent Damage
Report if the adverse event resulted in a substantial disruption of a person’s ability to conduct normal life functions, i.e., the adverse event resulted in a significant, persistent or permanent change, impairment, damage or disruption in the patient’s body function/structure, physical activities and/or quality of life.
Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly
The most common local and systemic adverse reactions to Fluzone High-Dose vaccine include pain, erythema, and swelling at the injection site; myalgia, malaise, headache, and fever. Other adverse reactions may occur. Fluzone High-Dose vaccine should not be administered to anyone with a known hypersensitivity (eg, anaphylaxis) to any vaccine component, including egg protein, or to a previous dose of any influenza vaccine.
If Guillain-Barre syndrome has occurred within 6 weeks following previous influenza vaccination, the decision to give Fluzone High-Dose vaccine should be based on careful consideration of the potential benefits and risks. Vaccination with Fluzone High-Dose vaccine may not protect all individuals.
Before administering Fluzone High-Dose vaccine, please see accompanying full Prescribing Information.